Cantabio Pharmaceuticals Inc (CTBO)
1.01
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Cantabio Pharmaceuticals Cash from Financing (TTM): 1.055M for Dec. 31, 2018
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2018 | 1.055M |
September 30, 2018 | 0.6635M |
June 30, 2018 | 0.8385M |
March 31, 2018 | 0.7005M |
December 31, 2017 | 0.7953M |
September 30, 2017 | 0.7756M |
June 30, 2017 | 0.6953M |
March 31, 2017 | 0.9533M |
December 31, 2016 | 0.7207M |
September 30, 2016 | 0.8489M |
June 30, 2016 | 0.9516M |
March 31, 2016 | 0.6166M |
Date | Value |
---|---|
December 31, 2015 | 0.4843M |
September 30, 2015 | 0.2415M |
June 30, 2015 | 0.0448M |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.0059M |
June 30, 2014 | 0.0301M |
March 31, 2014 | 0.0389M |
December 31, 2013 | 0.0619M |
September 30, 2013 | 0.0619M |
June 30, 2013 | 0.037M |
March 31, 2013 | 0.023M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
Q BioMed Inc | 0.8491M |
NVN Liquidation Inc | 19.55M |
Affymax Inc | -- |
Scopus BioPharma Inc | 2.217M |
Statera BioPharma Inc | -1.597M |